Critical
returns
Targeting the root cause of high-costs.

We move
where it matters.
We are here to combat the bifurcation of access and outcomes in critical industries, starting with healthcare and Main Street productivity. We help unlock distribution channels early and efficiently, and select the best board members at Series A.
Clinically diagnosed mental disorders cost the U.S. over $300Bn per year.*
So we invest in clinically-driven tech companies targeting those disorders by improving access to therapists and medications.
The initial success rate of IVF for U.S. families is 21.3%, leading to elevated costs that exceed over $10K on average, even with insurance coverage (offered by only 22 states as of 2024).*
So we invest in software that expands access to fertility care and helps reproductive endocrinologists streamline patient management, improve clinical decision-making, and deliver better care at scale.
99.9% of U.S. businesses are small businesses, yet over 40% still use paper or spreadsheets for daily operations.*
So we invest in solutions that bring modern software and automation to Main Street—industries like auto repair, logistics, and food service that have been historically overlooked by tech.

Who we
believe in
We partner with founders who are equal parts daring and self-aware— the ones who look for deep-rooted problems where the masses tend to look away. Through early funding and ongoing collaboration, we enable their creative solutions, so they can deliver positive outcomes to our frontline workers, our communities, and our future.
How we partner
We supply seed funding so solutions can take root. Our strategy moves bottom lines, and shatters the status quo, producing outcomes in sectors that are often overlooked. Our sweet spot is post first customer, but pre product market fit.
Our approach
Investment at
pre-seed/seed
To multi-stage investors
and mid-size customers
support
Operating model
deep dives
From top operators that we've built
working relationships with